Effect of long-term valproic acid administration on the efficiency of carnitine reabsorption in humans

被引:18
作者
Stadler, DD
Bale, JF
Chenard, CA
Rebouche, CJ
机构
[1] Univ Iowa, Coll Med, Dept Pediat, Program Human Nutr, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Med, Gen Clin Res Ctr, Iowa City, IA 52242 USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1999年 / 48卷 / 01期
关键词
D O I
10.1016/S0026-0495(99)90013-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To elucidate the etiology of valproic acid-induced carnitine deficiency, we tested the hypothesis that long-term valproic acid administration decreases the rate of carnitine reabsorption. Thirteen healthy men participated in a 34-day protocol in which carnitine clearance was measured before and after 28 days of valproic acid administration. During valproic acid administration (days 6 to 33), plasma free and total carnitine concentrations decreased (18% and 12%, respectively, P <.05) by 16 days, but returned to pretreatment concentrations by 28 days. From day 14 to day 30, the rate of free carnitine excretion was 50% lower than at baseline (day 4, P <.05). Free and total carnitine clearance, indexed to the glomerular filtration rate, was lower after valproic acid administration (P <.01). Contrary to our hypothesis, after 28 days of valproic acid administration, the rate of carnitine reabsorption was enhanced independent of the glomerular filtration rate and filtered load. Changes in the plasma concentration, rate of excretion, and clearance were specific for carnitine and were not generalized in magnitude or direction to the other amino acids. We conclude:hat the kidney adapts to conserve carnitine during valproic acid administration and therefore does not cause valproic acid-induced carnitine depletion in adults. Copyright (C) 1999 by W.B. Saunders Company.
引用
收藏
页码:74 / 79
页数:6
相关论文
共 26 条
[1]  
BLOCH AS, 1988, MODERN NUTR HLTH DIS, P1514
[2]  
CASTROGAGO M, 1990, INT PEDIAT, V5, P54
[3]   METHOD FOR DETERMINATION OF CARNITINE IN PICOMOLE RANGE [J].
CEDERBLA.G ;
LINDSTED.S .
CLINICA CHIMICA ACTA, 1972, 37 (NMAR) :235-&
[4]  
CG D., 1980, RENAL FUNCTION TESTS, P49
[5]  
COULTER DL, 1995, J CHILD NEUROL S, V10
[6]  
IZUTSU A, 1979, LIN CHEM, V25, P1093
[7]  
KONIG SA, 1994, EPILEPSIA, V35, P1005
[8]   IMPAIRED FATTY-ACID OXIDATION IN CHILDREN ON VALPROIC ACID AND THE EFFECT OF L-CARNITINE [J].
KOSSAK, BD ;
SCHMIDTSOMMERFELD, E ;
SCHOELLER, DA ;
RINALDO, P ;
PENN, D ;
TONSGARD, JH .
NEUROLOGY, 1993, 43 (11) :2362-2368
[9]   REVERSIBLE FANCONI SYNDROME-ASSOCIATED WITH VALPROATE THERAPY [J].
LANDE, MB ;
KIM, MS ;
BARTLETT, C ;
GUAYWOODFORD, LM .
JOURNAL OF PEDIATRICS, 1993, 123 (02) :320-322
[10]   SERUM CARNITINE DURING VALPROIC ACID THERAPY [J].
LAUB, MC ;
PAETZKEBRUNNER, I ;
JAEGER, G .
EPILEPSIA, 1986, 27 (05) :559-562